iPD3 is a partnership between The University of California, San Francisco and The University of Maryland, Baltimore that aims to level the playing field with respect to pediatric therapeutics development.  Comprised of leaders in pediatrics and pharmaceutical sciences, iPD3 is a "one-stop-shop" for consulting and implementation of drug and device development for pediatric applications.